Associate Professor, Pediatric Surgery, University of Texas Medical School, Houston
Family Medicine
Dr. Yong F. Li, MD
|
|
Give Review
Dr. Yong F. Li practices Family Medicine. He went to medical school at Shanghai Medical University. He received 4 awards: "Diabetes Recognition Program", "Patient-Centered Medical Home Recognition Program", "Heart/Stroke Recognition Program" and "Physician Practice Connections Recognition Program". Doctor Yong F. Li, MD is also published. He has 58 publications published. The lastest publication: "Toxicity and bioaccumulation of copper in Limnodrilus hoffmeisteri under different pH values: Impacts of perfluorooctane sulfonate.'
Publications
- Effects of fluid shift on upper airway patency and neck circumference in normal-weight subjects.
- Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituxim...
- Immunogenicity of somatic mutations in human gastrointestinal cancers.
- Transgenic expression of human amphiregulin in mouse skin: Inflammatory epidermal hyperplasia and enlarged sebaceous glands.
- A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response.
- Brain and muscle Arnt-like 1 promotes skeletal muscle regeneration through satellite cell expansion.
- Brenneria populi sp. nov., isolated from symptomatic bark of Populus×euramericana canker.
- Screening and investigation of a cyanine fluorescent probe for simultaneous sensing of glutathione and cysteine under single excitation.
- Wnt-RhoA Signaling Pathways in Fluoride-Treated Ameloblast-Lineage Cells.
- The Role of miR-200a in Mammalian Epithelial Cell Transformation.
- Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressions.
- microRNA-124 negatively regulates TLR signaling in alveolar macrophages in response to mycobacterial infection.
- A human ErbB2-specific TCR confers potent anti-tumor effector functions in genetically engineered primary cytotoxic lymphocytes.
- A Wnt/β-catenin negative feedback loop represses TLR-triggered inflammatory responses in alveolar epithelial cells.
- Regulation of p53-targeting microRNAs by polycyclic aromatic hydrocarbons: Implications in the etiology of multiple myeloma.
- The dichotomy of p53 regulation by noncoding RNAs.
- Enhancement of vitamin A combined vitamin D supplementation on immune response to Bacille Calmette-Guérin vaccine revaccinated in Chinese infants.
- The central role of EED in the orchestration of polycomb group complexes.
- The toxicity of cadmium to three aquatic organisms (Photobacterium phosphoreum, Daphnia magna and Carassius auratus) under different pH levels.
- Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity.
- MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy.
- Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells.
- Mutated PPP1R3B Is Recognized by T Cells Used To Treat a Melanoma Patient Who Experienced a Durable Complete Tumor Regression.
- Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Ritu...
- MYC/BCL2 protein co-expression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expres...
- Inverse relationship between long-chain n-3 fatty acids and risk of sudden cardiac death in patients starting hemodialysis.
- CD30 expression defines a novel subset of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from The Internationa...
- MicroRNA expression patterns in indeterminate inflammatory bowel disease.
- Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with rituximab-CHOP: a report from an International DLBCL Ritu...
- The A-kinase anchoring protein Yotiao facilitates complex formation between type 9 adenylyl cyclase and the IKs potassium channel in heart.
- TH-A-213AB-11: Deliverable Optimization Incorporating Monitor Unit Constraints for Intensity Modulated Proton Therapy Treatment Planning.
- SU-C-BRCD-04: Development of An Efficient and Effective Patient Specific QA Program for IMPT.
- MicroRNA-96 Is a Post-Transcriptional Suppressor of Anaplastic Lymphoma Kinase Expression.
- Phase Selection Enabled Formation of Abrupt Axial Heterojunctions in Branched Oxide Nanowires.
- Investigation of VUV Photodissociation Propensities Using Peptide Libraries.
- PNAS Plus: An antigenic peptide produced by reverse splicing and double asparagine deamidation.
- Irradiation enhances human T-cell function by upregulating CD70 expression on antigen-presenting cells in vitro.
- Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1.
- The importance of peptide detectability for protein identification, quantification, and experiment design in MS/MS proteomics.
- A template and catalyst-free metal-etching-oxidation method to synthesize aligned oxide nanowire arrays: NiO as an example.
- Combinatorial libraries of synthetic peptides as a model for shotgun proteomics.
- A bayesian approach to protein inference problem in shotgun proteomics.
- "Reverse ecology" and the power of population genomics.
- Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions.
- Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond.
- Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy.
- Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression.
- Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy.
- T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene product.
- Identification of a colorectal tumor-associated antigen (COA-1) recognized by CD4(+) T lymphocytes.
- Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma.
- Expression of a "self-"antigen by human tumor cells enhances tumor antigen-specific CD4(+) T-cell function.
- Complete nucleotide sequence of plasmid Rts1: implications for evolution of large plasmid genomes.
- Factors associated with patient and provider delays for tuberculosis diagnosis and treatment in Asia: a systematic review and meta-analysis.
- Shear bond strength of dentin and deproteinized enamel of amelogenesis imperfecta mouse incisors.
- Increased expression of connective tissue growth factor and transforming growth factor-Beta-1 in atrial myocardium of patients with chronic atrial fibrillation.
- Toxicity and bioaccumulation of copper in Limnodrilus hoffmeisteri under different pH values: Impacts of perfluorooctane sulfonate.
Schools
Shanghai Medical University
University of Texas Health Science Center at Houston
Doctors Specialties
- Family Medicine
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Assurant Health
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access
- Coventry Health Care
- Choice Care PPO
- Medicaid
- MultiPlan PPO
- PHCS Network PPO
- Principal Financial Group
- Choice Plus POS
- Options PPO
- United Healthcare
Awards
- Diabetes Recognition Program
- Patient-Centered Medical Home Recognition Program
- Heart/Stroke Recognition Program
- Physician Practice Connections Recognition Program
Education
-
University of Texas Health Science Center -
Shanghai Medical University
Hospital
-
Baylor St. Luke's Medical Center
Drug Facts
| NPI NUMBER | 1003977836 | |
| NPPES Provider LastName | LI | |
| NPPES Provider FirstName | YONG | |
| NPPES Provider ZIPCode | 549521115 | |
| NPPES Provider State | WI | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 6753.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 13.0 | |
| Percent Opioid Claims | 0.19 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1003977836 |
| Last Name Of The Provider | LI |
| First Name Of The Provider | YONG |
| View All |
Similar Doctors
|
Dr. Ekanem O. Ohia, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Na L. Vang, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kenneth Stanley, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Maria M. Palasi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Saul Torres Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Branka Kosarac, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arian Haxhillari, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Rupali R. Kadakia, MD
This Doctor is OpenDoctor Recommended.
|